Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxyacyl-CoA dehydrogenase pseudogene (ENSG00000261072) is a nonfunctional DNA sequence with high similarity to the hydroxyacyl-CoA dehydrogenase gene, a mitochondrial enzyme involved in the beta-oxidation of fatty acids. While the functional gene plays important metabolic and clinical roles, such as in fatty acid oxidation disorders, this pseudogene does not encode a protein and has no known direct role in biological function or disease. It is not considered a therapeutic target, nor does it have established utility in pharmacology or biomarker research[3][4][5]. Context and clarification: - If you are seeking information about the *functional* hydroxyacyl-CoA dehydrogenase, refer to the gene *HADH* (Ensembl: ENSG00000138796), which encodes an active enzyme with metabolic and clinical significance[1][5][6][7]. - The distinction is important: **pseudogenes** like ENSG00000261072 are generally excluded from drug target lists in pharmacology and biomedical research. If you require information on the functional enzyme instead, such as "Hydroxyacyl-CoA dehydrogenase" (HADH), please clarify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxyacyl-CoA dehydrogenase pseudogene.